Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Behav Brain Res ; 302: 200-12, 2016 Apr 01.
Article in English | MEDLINE | ID: mdl-26777900

ABSTRACT

Women are more susceptible than men to develop anxiety disorders, however, the mechanisms involved are still unclear. In this study, we investigated the role of group I metabotropic glutamate receptors (mGluRs), a target for anxiety disorders, and whether estradiol may modulate conflict-based anxiety in female rats by using the Vogel Conflict Test (VCT). We used ovariectomized female rats with high (OVX+EB) and low (OVX) estradiol levels and intact male rats to evaluate sex differences. Infusion of (S)-3,5-Dihydroxyphenylglycine (DHPG), a group I mGluR agonist, into the basolateral amygdala, a region involved in anxiety-responses, statistically increased the number of shocks in OVX, but not OVX+EB female rats at 0.1, nor at 1.0 µM. In contrast, DHPG statistically decreased the number of shocks in male rats at 1.0 µM only. DHPG (0.1 µM) increased the number of recoveries in OVX, but not OVX+EB or male rats. Sex differences were detected for the number of shocks, recoveries and punished licks, where female rats displayed more conflict than male rats. Western blot analyses showed that protein expression of mGluR1, but not mGluR5 was higher in OVX+EB>OVX>male rats in the amygdala, whereas no significant differences were detected in the hippocampus, olfactory bulb and/or the periaqueductal gray. Therefore, DHPG produced paradoxical effects that are sex dependent; producing anxiolytic-like effects in female rats, while anxiogenic-like effects in male rats according to the VCT. These results highlight the importance of including female experimental models to underpin the neural circuitry of anxiety according to sex and for the screening of novel anxiolytic compounds.


Subject(s)
Amygdala/metabolism , Anxiety/pathology , Anxiety/psychology , Conflict, Psychological , Receptors, Metabotropic Glutamate/metabolism , Sex Characteristics , Amygdala/drug effects , Analysis of Variance , Animals , Anti-Anxiety Agents/pharmacology , Anti-Anxiety Agents/therapeutic use , Anxiety/drug therapy , Buprenorphine/pharmacology , Buprenorphine/therapeutic use , Conditioning, Psychological/drug effects , Disease Models, Animal , Dose-Response Relationship, Drug , Estradiol/administration & dosage , Female , Gene Expression Regulation/drug effects , Male , Methoxyhydroxyphenylglycol/analogs & derivatives , Methoxyhydroxyphenylglycol/therapeutic use , Ovariectomy , Rats , Rats, Sprague-Dawley
2.
Behav Processes ; 99: 73-80, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23792034

ABSTRACT

The illicit use of anabolic androgenic steroids (AAS) has gained popularity among adolescents in the last decade. However, although it is known that exposure to AAS impairs cognition in adult animal models, the cognitive effects during adolescence remain undetermined. An inhibitory avoidance task (IAT) was used to assess the effect of AAS (17α-methyltestosterone; 17α-meT--7.5 mg/kg) in male and female periadolescent rats. A single injection of 17α-meT immediately before the footshock produced significant impairment of inhibitory avoidance learning in males but not females. Generalized anxiety, locomotion, and risk assessment behaviors (RAB) were not affected. Our results show that exposure to a single pharmacological dose of 17α-meT during periadolescence exerts sex-specific cognitive effects without affecting anxiety. Thus, disruption of the hormonal milieu during this early developmental period might have negative impact on learning and memory.


Subject(s)
Avoidance Learning/drug effects , Methyltestosterone/pharmacology , Animals , Anxiety/psychology , Dose-Response Relationship, Drug , Fear/psychology , Female , Male , Psychomotor Performance/drug effects , Rats , Rats, Sprague-Dawley , Sex Characteristics , Vagina/physiology
3.
Pharmacol Biochem Behav ; 101(3): 369-78, 2012 May.
Article in English | MEDLINE | ID: mdl-22326382

ABSTRACT

Anxiety disorders are more prevalent in females than males. The underlying reasons for this gender difference are unknown. Metabotropic glutamate receptors (mGluRs) have been linked to anxiety and it has been shown that interaction between estrogen receptors and mGluRs modulate sexual receptivity in rats. We investigated the role of mGluRs in anxiety-related behaviors in ovariectomized female rats with (OVX+EB) or without (OVX) estradiol implants. We centrally infused (s)-3,5-dihydroxyphenylglycine (DHPG), a group I mGluR agonist, into the basolateral amygdala (BLA) of OVX+EB and OVX rats at 0.1 and 1.0 µM. Male rats that normally have low estradiol levels were used to compare with OVX rats. Generalized anxiety, explorative activity and detection and analysis of threat were analyzed in the elevated plus maze (EPM) and risk assessment behaviors (RABs). DHPG (1.0 µM) increased the percentage of time spent in- and entries into- the open arms in OVX+EB, but not in OVX or male rats. Flat-back approaches and stretch-attend postures, two RABs, were significantly reduced by DHPG (0.1 and 1.0 µM) in OVX+EB rats only. DHPG did not modulate rearing and freezing, behaviors related to exploration and fear-like behavior, respectively. However, DHPG (1.0 µM) increased head dipping and decreased grooming behaviors in OVX rats, suggesting a weak explorative modulation. The effects of DHPG observed in OVX+EB, were blocked by 50 µM of (RS)-1-aminoindan-1,5-dicarboxylic acid (AIDA), a mGluR1 antagonist. AIDA and/or estradiol did not modulate anxiety and or RABs. Our results show that intra-BLA infusion of DHPG exerts an anxiolytic-like effect in OVX+EB, but not in OVX or male rats. This effect seems to depend upon mGluR1 subtype activation. Our findings led us to suggest that the effects observed in OVX+EB rats might be due to an interaction at the membrane level of estrogen receptors with mGlu1 within the BLA.


Subject(s)
Amygdala/drug effects , Amygdala/physiology , Anxiety/physiopathology , Receptors, Metabotropic Glutamate/physiology , Amygdala/anatomy & histology , Amygdala/physiopathology , Animals , Anxiety/drug therapy , Anxiety/psychology , Behavior, Animal/drug effects , Behavior, Animal/physiology , Estradiol/pharmacology , Female , Glycine/administration & dosage , Glycine/analogs & derivatives , Indans/administration & dosage , Male , Maze Learning/drug effects , Ovariectomy , Ovary/physiology , Rats , Rats, Sprague-Dawley , Receptors, Estrogen/physiology , Receptors, Metabotropic Glutamate/agonists , Receptors, Metabotropic Glutamate/antagonists & inhibitors , Resorcinols/administration & dosage
4.
Behav Neurosci ; 120(3): 632-40, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16768615

ABSTRACT

Three different behavioral tasks were used to study the role of the neurosteroid 5alpha -androstane-3alpha, 17beta-diol (3alphaDIOL) in affective components of behavior when infused into the basolateral amygdala (BLA) of both sexes. Female rats were ovariectomized; half received implants containing estradiol benzoate (OVX-EB), whereas the other half received empty implants (OVX). Male rats were gonadally intact. No differences were noted in male behavior according to the conditioned place preference (CPP) test, the modified Vogel conflict test (VCT), or the elevated plus maze (EPM) upon infusion of 3alphaDIOL. In contrast, 3alphaDIOL modulated CPP and VCT performance among female rats. Therefore, the authors propose that 3alphaDIOL modulates affect through the BLA via a sex-specific mechanism.


Subject(s)
Amygdala/drug effects , Conditioning, Operant/drug effects , Estradiol/analogs & derivatives , Sex Characteristics , Spatial Behavior/drug effects , Analysis of Variance , Animals , Behavior, Animal/drug effects , Behavior, Animal/physiology , Estradiol/pharmacology , Estrogens/blood , Estrogens/pharmacology , Exploratory Behavior/drug effects , Female , GABA Agonists/pharmacology , GABA Antagonists/pharmacology , Male , Maze Learning/drug effects , Motor Activity/drug effects , Muscimol/pharmacology , Ovariectomy/methods , Pyridazines/pharmacology , Radioimmunoassay/methods , Rats , Rats, Sprague-Dawley , Steroids/pharmacology
5.
Brain Res ; 1062(1-2): 1-8, 2005 Nov 16.
Article in English | MEDLINE | ID: mdl-16256086

ABSTRACT

We have studied the effects of groups I, II, and III metabotropic glutamate receptor (mGluR) agonists and antagonists on pyloric activity in the stomatogastric ganglion (STG) of the Caribbean spiny lobster Panulirus argus. We have found that agonists for all three groups of mGluRs modify the pyloric output. The group I agonist, l-quisqualic acid (l-QA), activated the pyloric central pattern generator (CPG). When the pyloric rhythm was partially suppressed by sucrose-block of input fibers in the stomatogastric nerve (stn), l-QA accelerated the rhythmic activity. In addition, the number of spike discharges was increased in pyloric motoneurons: pyloric (PY), and lateral pyloric (LP). In completely blocked preparations, a slow pyloric rhythm was initiated by l-QA. Groups II and III agonists exerted an inhibitory effect on pyloric activity. The group II agonist, (2S,1'S,2'S)-2-(Carboxycyclopropyl)glycine (L-CCG-I), decreased both the frequency of the pyloric rhythm and the number of spike discharges in the motoneurons: ventricular dilator (VD), PY, and LP. The effects of L-CCG-I were dose-dependent. The group III agonist, l-(+)-2-Amino-4-phosphonobutyric acid (l-AP4), slightly decreased the frequency of the pyloric rhythm and suppressed spike discharges in the VD neuron. All effects of mGluR agonists were reversible. The effect of l-QA was blocked by the broad spectrum mGluR antagonist (S)-Methyl-4-carboxyphenylglycine (MCPG). The inhibitory effect of L-CCG-I was prevented by MCPG and by the group II/III mGluR antagonist (RS)-alpha-Methyl-4-phosphonophenylglycine (MPPG), and was partially blocked by the group II mGluR antagonist (RS)-1-amino-5-phosphonoindan-1-carboxylic acid (APICA). The inhibitory effect of l-AP4 was blocked by MPPG and partially blocked by APICA.


Subject(s)
Action Potentials/drug effects , Excitatory Amino Acid Agents/pharmacology , Ganglia, Invertebrate/drug effects , Periodicity , Receptors, Metabotropic Glutamate/agonists , Stomach/innervation , Analysis of Variance , Animals , Dose-Response Relationship, Drug , In Vitro Techniques , Nerve Net/drug effects , Palinuridae , Receptors, Metabotropic Glutamate/antagonists & inhibitors , Receptors, Metabotropic Glutamate/classification , Statistics, Nonparametric , Stomach/drug effects , Synaptic Transmission/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...